Vitamin E in diabetes: Increased oxidative stress and its prevention as a strategy to prevent vascular complications?

International Journal for Vitamin and Nutrition Research

Volumn 69, Issue 3, 1999, Pages 206-212

  Rösen, Peter ^a   Toeller, Monika ^a  

^a HEINRICH HEINE UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0345593791     PISSN: 03009831     EISSN: None     Source Type: Journal    
DOI: 10.1024/0300-9831.69.3.206     Document Type: Conference Paper

References (62)

1. Zimmet, P. (1991) Diabetes care and prevention - around the world in 80 days. In: Diabetes (Rifkin, H., Colwell, J. A., Taylor, S. I., eds), pp. 721-729, Elsevier, Amsterdam.
2. Schernthaner, G. (1996) Cardiovascular mortality and morbidity in type 2 diabetes mellitus. Diab. Res. Clin. Pract. 31 (suppl.), S3-S14.
3. Laakso, M., Lehtoo, S., Penttilä, I. and Pyörälä, K. (1993) Lipids and lipoproteins predicting coronary heart disease mortality and morbidity in patients with noninsulindependent diabetes. Circulation 88, 1421-1430.
4. Kannel, W. B. and McGee, D. L. (1979) Diabetes and cardiovascular risk factors. The Framingham Study. Circulation 1, 8-13.
5. Gey, K. F., Puska, P., Jordan, P. and Moser, U. K. (1991) Inverse correlation between plasma vitamin E and mortality from ischemic heart disease in cross-cultural epidemiology. Am. J. Clin. Nutr. 53, 326S-334S.
6. Riemersma, R. A., Wood, D. A. MacIntyre, C. C., Elton, R. A., Gey, K. F. and Oliver, M. F. (1991) Risk of angina pectoris and plasma concentrations of vitamins A, C and E and carotene. Lancet 337, 1-5.
7. Stampfer, M. J., Hennekens, C. H., Marrison, J. E., Colditz, G. A., Rosner, B. and Willet, W. C. (1993) Vitamin E consumption and the risk of coronary disease in woman. N. Engl. J. Med. 328, 1444-1449.
8. Rimm, E. B., Stampfer, M. J., Ascherio, A., Giovannuci, E., Colditz, G. A. and Willet, W. C. (1993) Vitamin E consumption and the risk of coronary heart disease in men. N. Engl. J. Med. 328, 1450-1456.
9. Nourooz-Zadeh, J., Tajaddini-Sarmadi, J., McCarthy, S., Betteridge, D. J. and Wolff, S. P. (1995) Elevated levels of authentic plasma hydroperoxides in NIDDM. Diabetes 44, 1054-1058.
10. Nourooz-Zadeh, J., Halliwell, B., Tritschler, H. J. and Betteridge, D. J. (1981) Decreased lipid standardised plasma α-tocopherol in non-insulin-dependent diabetes mellitus. Diabetes & Stoffw. 6 (suppl. 2), 20-23.
11. Nishigaka, I., Hagihara, M., Tsunekawa, H., Maseki, M. and Yagi, K. (1981) Lipid peroxide levels of serum lipoprotein fractions of diabetic patients. Biochem. Med. 25, 373-378.
12. Bellomo, G., Maggi, E., Polli, M., Agosta, F. G., Bollati, P. and Finardi, G. (1991) Autoantibodies against oxidatively modified low density lipoproteins in NIDDM. Diabetes 44, 60-66.
13. Roesen, P. and Tchoepe, D. (1991) Vitamin E and Diabetes. Fat Sci. Technol. 11, 425-431.
14. Hunt, J. V., Smith, C. T. and Wolff, S. P. (1990) Autoxidative glycosylation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39, 1420-1424.
15. Pratico, D., Reilly, M., Lawson, J. A. and Fitzgerald, G. A. (1997) Novel indices of oxidant stress in cardiovascular disease: specific analysis of F2-isoprostanes. Agents Actions Suppl. 48, 24-41.
16. 2α levels are elevated in individuals with NIDDM. FEBS Lett. 368, 225-229.
17. 2α in diabetes mellitus. Effects of tight control and vitamin E supplementation. Diabetes 46 (suppl. 1), 13A.
18. Jain, S. K., MeVie, R., Duett, J. and Herbst, J. J. (1989) Erythrocyte membrane lipid peroxidation and glycosylated hemoglobin in diabetes. Diabetes 38, 1539-1543.
19. Bellomo, G., Maggi, E., Palladini, G., Perugini, C. and Seccia, M. (1997) Oxidation of low density lipoproteins and vitamin E status in non insulin dependent diabetes mellitus (NIDDM). Diabetes & Stoffw. 6 (suppl. 2), 29-33.
20. Leonhardt, W., Hanefeld, M., Lattke, P. and Jarob, W. (1997) Vitamin E Mangel und Oxidierbarkeit der Low Density Lipoproteine bei Typ I und Typ II Diabetes: Einfluss der Qualität der Stoffwechselkontrolle. Diabetes & Stoffw. 6 (suppl. 2), 24-28.
21. Reavan, P. D., Herold, D. A., Barnett, J. and Edelmann, S. (1995) Effects of vitamin E on susceptibility of LDL and LDL subfractions to oxidation and on protein glycation in NIDDM. Diabetes Care 18, 807-816.
22. Minor, R. L., Myers, P. R., Guerra, R., Bates, J. N. and Harrison, D. G. (1990) Dietinduced atherosclerosis increases the release of vascular relaxing factor. J. Clin. Invest. 86, 2109-2116.
23. Keaney, J. F., Gaziano, J. M., Xu, A., Frei, B., Curran-Celentano, J., Shwaery, G. T., Loscalzo, J. and Vita, J. A. (1994) Low dose atocopherol improves and high tocopherol worsens endothelial vasodilator function in cholesterol-fed rabbits. J. Clin. Invest, 93, 844-851.
24. Ohara, Y., Peterson, T. E. and Harrison, D. G. (1993) Hypercholesterolemia increases endothelial superoxide anion production. J. Clin. Invest. 91, 2546-2551.
25. 2+/EDRF signalling are due to generation of superoxide anions. Diabetes 45, 1386-1395.
26. Hunt, J. A., Smith, C. C. T. and Wolff, S. P. (1990) Autoxidative glycosy lation and possible involvement of peroxides and free radicals in LDL modification by glucose. Diabetes 39, 1420-1424.
27. Giardino, I., Edelstein, D. and Brownlee, M. (1996) BCL-2 expression or antioxidants prevent hyperglycemia induced formation of intracellular advanced glycation endproducts in bovine endothelial cells. J. Clin. Invest. 97, 1422-1428.
28. Van, S. I., Schmidt, A. M., Anderson, G. M., Zhang, J., Brett, J., Zou, Y. S., Pinsky, D. and Stern, D. (1994) Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins. J. Biol. Chem. 269, 9889-9897.
29. Straub, R. H., Rokitzli, L., Schumacher, T., Hillmann, C., Palitzsch, K. D. and Scholmerich, J. (1993) No evidence of deficiency of vitamins A, E, beta-carotene, B1, B2, B6, B12 and folate in neuropathic type II diabetic women. Int. J. Vitam. Nutr. Res. 63, 239-240.
30. Blanchard, P., Anton, B., Larousse, C., Auget, D., Mainard, F., Charbonnel, B. and Krempf M. (1992) Plasma vitamin E, non-high-density lipoprotein cholesterol, and apolipoprotein B in diabetic patients. Clin. Chem. 38, 2339-2340.
31. Karpen, C. W., Cataland, S., D'Orisiso, D. and Panaganamal, R. M. (1985) Production of 12-HETE and vitamin E status in platelets of type 1 diabetes subjects. Diabetes 34, 526-531.
32. Toeller, M., Klischan, A., Heitkamp, G., Schumacher, W., Milne, R., Buyken, A., Karamanos, B. and Gries F. A. (1996) Nutritional intake of 2868 IDDM patients from 30 centres in Europe. Diabetologia 39, 929-939.
33. Simon-Schnass, I., Rosak, C., Tritschler, H. J. and Roesen, P. (1997) Alpha-Tocopherolaufnahme und -zufuhr bei Typ II Diabetikern. Diabetes & Stoffw. 6 (suppl. 2), 16-19.
34. Maxwell, S. R. J., Thomason, H., Sandler, D., Leguen, C., Baxter, M. A., Thorpe, G. H. G., Jones, A. F. and Barnett, A. H. (1997) Antioxidant status in patients with uncomplicated insulin-dependent and non-insulin-dependent diabetes mellitus. Eur. J. Clin. Invest. 27, 484-490.
35. Bischof, F. (1997) Ernährungsverhalten von über 40jährigen Diabetikern in Deutschland. Master Arbeit, Universität Ulm.
36. 2 in human umbilical vein endothelial cells cultured in high glucose. Diabetologia 37, 264-269.
37. Ceriello, A., Bartolotti N., Falleti, E., Taboga C., Tobutti, L., Crescentini, A., Motz, E., Lizzio, S., Russo, A. and Bartoli. E. (1997) Total radical-trapping antioxidant parameter in NIDDM patients. Diab. Care 20, 194-197.
38. Ross, R. (1993) The pathogenesis of atherosclerosis: A perspective for the 1990s. Nature 362, 801-809.
39. Brand, K., Page, S., Rogler, G., Bartsch, A., Brandi, R., Knuechel, R., Page, M., Kaltschmidt, C., Baeuerle, P. A. and Neumeier, D. (1996) Activated transcription factor nuclear factor-kappa B is present in atherosclerotic lesion. J. Clin. Invest. 97, 1715-4722.
40. Rösen, P., Ballhausen, T., Bloch, W. and Addicks, K. (1995) Endothelial relaxation is disturbed by oxidative stress in the diabetic rat heart: Influence of tocopherol as antioxidant. Diabetologia 8, 1157-1168
41. Dietrich, D., Skepee, J., Diederich, A. and Dai, F. X. (1994) Endothelial dysfunction in mesenteric resistance arteries of diabetic rats: Role of free radicals. Am. J. Physiol. 266, H 1 153-H1161.
42. Pieper, G. M. and Gross, G. J. (1988) Oxygen free radicals abolish endothelium dependent relaxation in diabetic rat aorta. Am. J. Phyiol. 255, H825-H833.
43. Tesfamariam, B. (1994) Free radicals in diabetic endothelial cell dysfunction. Free Radical Biol. Med. 16, 383-391.
44. Cohen, R. A (1993) Dysfunction of vascular endothelium in diabetes mellitus. Circulation 87 (suppl. V), V67-V76.
45. Nitenberg, A., Valensi, P., Sachs, R., Dah, M., Aptecar, E. and Attali, J. R. (1993) Impairment of coronary vascular reserve and Ach induced coronary vasodilation in diabetic patients with angiographically normal coronary arteries and normal left ventricular systolic function. Diabetes 42, 1017-1025.
46. Schmidt, H. H. and Walter, U. (1994) NO at work. Cell 78, 919-925.
47. Rösen, P., Hönack, C., Müssig, K., Bloch, W. and Addicks, K. (1998) Influence of AT I receptor inhibition on cardiac function and structure of diabetic rats. In: Angiotensin II Receptor Blockade: Physiological and Clinical Implications (Dhalla, N. S., Zahradka, Pm, Dixon, I. M. C., Beamish, R. E. (eds), Kluwer Academic Press, Boston (in press).
48. Lyons, T. J (1991) Oxidised low density lipoproteins: A role in the pathogenesis of atherosclerosis in diabetes? Diabetes Med. 8, 411-419.
49. Jessup, W. (1996) Oxidised lipoproteins and nitric oxide. Curr. Opin. Lipidology. 7, 274-280.
50. Brown, A. J. (1996) Atherosclerosis: cell biology and lipoproteins. Curr. Opin. Lipidology 7, U 162-U 167.
51. Rajagopalan, S., Meng, X. P., Ramasamy, S., Harrison, D. G. and Galis, Z. S. (1996) Reactive oxygen species produced by macrophage-derived foam cells regulate the activity of vascular matrix metalloproteinases in vitro. J. Clin. Invest. 98, 2572-2579.
52. Falk, E., Shah, P. K. and Fuster, V. (1995) Coronary plaque disruption. Circulation 92, 657-671.
53. Rösen, P., Du, X. L. and Tschöpe, D. (1998) Role of oxygen derived radicals for vascular dysfunction in the diabetic heart: prevention by a-tocopherol? Mol. Cell. Biochem. (in press).
54. Kushi, L. H., Folsorn, A. R., Prineas, R. J., Mink, P.J., Wu, Y. and Bostick, R. M. (1996) Dietary antioxidant vitamins and death from coronary heart disease in postmenopausal women. N. Engl. J. Med. 334, 1156-1162.
55. Blot, W. J., Li, L. Y., Taylor, P. R., Guo, W., Dawsey S., Wang, G. Q., Yang, C. S., Zheng, S. F., Gail, M., Li, G. Y., Yu, Y., Liu, B., Tangrea, J., Sun, Y., Liu, F., Fraumeni J. F. Jr., Zhang, Y. and Li, B. (1993) Nutrition intervention trials in Linxian, China: Supplementation with specific vitamin/mineral combinations, cancer incidence, and disease specific mortality in the general population. J. Nat. Cancer Inst. 85, 1483-1492.
56. The Alpha-Tocopherol, Beta-Carotene Cancer Prevention Study Group (1994) The effect of vitamin E and beta carotene on the incidence of lung cancer and other cancers in male smokers. N. Engl. J. Med. 330, 1029-1035.
57. Haeger, T. (1974) Long time treatment of intermittent claudication with vitamin E. Am. J. Clin. Nurr. 27, 1179-1181.
58. Livingston, P.D. and Jones, C. (1958) Treatment of intermittent claudication with vitamin E. Lancet 2, 602-604.
59. Williams, H. T. G., Fenna, D. and MacBeth, R. A. (1971) Alpha-tocopherol in the treatment of intermittent claudication. Surg. Gynecol. Obstet. 132, 662-666.
60. Stephens, N. G., Parsons, A., Schofield, P. M., Kelly, F., Cheeseman, K., Mitchinson, M. and Brown, M. I. (1996) Randomised controlled trial of vitamin E in patients with coronary disease: Cambridge Heart Antioxidant Study (CHAOS). Lancet 347, 781-786.
61. Hodis, H. N., Mack, W. J., LaBree, L. Cashin-Hemphill, L., Sevanian, A., Johnson, R. and Azen, S. P. (1995) Serial coronary angiographic evidence that antioxidant vitamin intake reduced progression of coronary artery atherosclerosis. JAMA 273, 1849-1854.
62. DeMaio, S. J., King, S. B., Lembo, N. J., Roubin, G. S., Hearn, J. A., Bliagavan, H. N. and Sgoutas, D. S. (1992) Vitamin E supplementation, plasma lipids and incidence of restenosis after percutaneous transluminal coronary angioplasty (PTCA). J. Am. Coil. Nutr. I 1, 68-73.